AML Insights – July-August Update: What’s New in the Field
Uncover the latest insights in acute myeloid leukemia – from novel immunotherapy targets like IGSF9 and CD84, to innovative treatment approaches such as vaccine-primed T cells, TLR2 agonism, and refined use of venetoclax. Explore how genomic profiling of extramedullary AML and updated relapse prognostic models are transforming diagnosis and disease management.
Don’t miss these exciting developments!
Relateret indhold
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen